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Current Research and 
Clinical Applications
Response to: Madsen MV, Gøtzsche PC, 
Hróbjartsson A. Acupuncture Treatment for Pain: 
Systematic Review of Randomised Clinical Trials 
with Acupuncture, Placebo acupuncture, and No 
Acupuncture Groups. 
BMJ 338:a3115, doi:10.1136/bmj.a3115 (Published 27 January 2009)
Zhen Zheng* PhD
This January, BMJ published a systematic 
review of acupuncture clinical trials for 
pain conditions. The authors were from 
Nordic Cochrane Centre in Denmark. 
They have been researching the placebo 
effect in medical interventions for a 
number of years.
The results of this paper were publicised 
in many newspapers, radio and online 
media, and caused a world wide 
discussion on whether acupuncture was 
effective. I believe most of you would 
have read the news or heard of the 
review. At the time of publication, I was 
busy working on three Human Research 
Ethics applications for a clinical trial we 
planned to conduct in Melbourne and 
paid little attention to the review. I said 
to myself it was just another such paper, 
failing to recognise its wide impact. 
Then two Human Research Ethics 
Committees questioned me about the 
implication of the review on our clinical 
trial. The committees wanted to know, 
given there was little difference between 
real and sham acupuncture as shown 
by the Madsen review, how we could 
justify the clinical trial we proposed and 
if we should consider adopting Madsen’s 
recommendations? A couple of weeks 
later, a potential patient told me that 
from his reading there was little evidence 
supporting the use of acupuncture 
for pain relief, and asked me what my 
opinions about acupuncture for pain 
management were. These incidents 
highlight the wide and strong impact of 
research on, not only further studies in 
the area, but also clinical practice.
ABOUT THE REVIEW 
So what is the review about and what 
are the recommendations? Madsen 
and colleagues wanted to know if real 
acupuncture was better than fake/sham 
acupuncture or no acupuncture for pain 
relief. To answer the questions, they 
conducted a comprehensive literature 
search and utilized a set of selection 
criteria. Briefly, they selected randomised 
controlled studies; (1) using invasive 
acupuncture as the real procedure; and 
(2) reporting pain intensity measured 
on a Visual Analogues Scale (VAS) or 
ranking scale. Thirteen studies with a 
total of 3025 patients were selected. The 
study conditions included post-operative 
pain, scar pain, tension-type headache, 
migraine, fibromyalgia, osteoarthritis 
and low back pain. They found that 
although there was a statistically 
significant difference between real 
and sham acupuncture in pain relief 
[Standard Mean Difference (SMD) 
–0.17], the effect was small, about 4 
mm on a 100 mm VAS, and clinically 
insignificant. The difference between 
real and no acupuncture groups was 
moderate (SMD –0.42). Furthermore, 
and contrary to the common view, the 
authors did not find any difference in 
pain relief between sham acupuncture 
using invasive methods and non-invasive 
methods. The authors concluded that 
the analgesic effect of acupuncture was 
clinically irrelevant and the psychological 
effect of acupuncture needs to be 
studied. 
The authors went further to 
recommend:
(1)  ‘…having the needling done by 
acupuncture naïve clinicians blinded 
to the hypothesis of the trial’; and 
(2) ‘…try to separate the effects 
involved: the physiological effect of 
needling at acupuncture sites or at 
other sites and psychological effect 
of the treatment…’
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ANALYSIS OF THE REVIEW
The authors attempted to answer an 
important question: the difference 
between real and sham acupuncture for 
treating painful conditions. Overall the 
review was executed with well-accepted 
methods and adequate statistical analysis. 
The two weaknesses of the review are the 
main threats to the validity of the study. 
Firstly, the review did not distinguish 
between chronic and acute pain in the 
analysis. Secondly it failed to assess the 
quality of acupuncture treatment.
Chronic pain differs from acute pain in its 
pathology and management approaches. 
Chronic pain is considered not just a 
symptom, but a disease in itself,1 whereas 
acute pain is often self-limiting and 
disappears as tissue heals. Furthermore, 
chronic pain affects one’s physical 
function, cognition and emotion. Due 
to the complexity of chronic pain, the 
International Association for the Study of 
Pain (IASP), the main organisation that 
promotes pain research, education and 
practice, advocates multidisciplinary pain 
management. ‘The Initiative on Methods, 
Measurement, and Pain Assessment 
on Clinical Trials (IMMPACT)’2 states 
that pain intensity is only one aspect of 
any pain condition. When assessing the 
efficacy of an intervention, one has to 
consider not only reduction in pain, but 
also improvement in physical function, 
quality of life and psychological status. 
Using pain intensity alone to judge the 
clinical use of a therapy is not adequate. 
Thus, using limited data, a single type of 
outcome assessment, or a single modality 
to judge the efficacy of acupuncture for 
pain, is also inadequate.
Even within chronic pain, there are 
various types. For instance, fibromyalgia 
(FM), a type of wide-spread pain, is quite 
different from commonly seen localised 
musculoskeletal conditions, such as knee 
pain. One study showed that both real 
and sham acupuncture increased the 
blood flow in the muscle of FM patients; 
whereas in the healthy humans, only real 
acupuncture had this effect.3 The results 
indicated that both types of acupuncture 
could be similarly effective in FM 
patients, possibly due to physiological, 
rather than psychological factors. 
Experienced acupuncturists would know 
that only shallow needling, similar to 
that used in sham acupuncture, should 
be used in FM patients at the early stages 
of treatment because patients are often 
extremely sensitive to needling.
Acupuncture is a complex intervention; 
even in its technique, it is more than 
just deqi and acupuncture points. Two 
questions students often ask about deqi 
and yet we do not have the answer are 
how long deqi sensation should be 
maintained and whether we need to 
produce deqi in all acupuncture points 
used in the treatment. These questions 
imply the fine techniques involved in 
needling. Let me illustrate the importance 
of this question with an example. 
In recent years, two clinical trials of 
acupuncture for tension-type headache 
were conducted in Germany.4,5 Both 
compared real with sham acupuncture, 
selected similar acupuncture points, and 
the treatment was delivered by physicians 
who had similar qualifications. The 
results were, however, different. For 
headache days, Melchart’s study showed 
no difference between real and sham 
acupuncture whereas Endres’s study 
found that real acupuncture reduced 
headaches by 2.3 headache-days more 
than sham acupuncture did. Fortunately 
the authors of the two studies published 
their research methods and conduct 
of the trials in great detail,6,7 which 
allowed in-depth comparison of the 
two trials. It became apparent that the 
administration of acupuncture and the 
adherence to protocol differed in the two 
trials. In the Melchart study, one of the 
eight main centres delivered 214 out of 
1507 sessions of treatment, and did not 
use two of the three mandatory points 
for 80% of their patients. ‘Deqi was 
achieved if possible’. In contrast, in the 
Endres study, mandatory points had to 
be needled in every patient and in every 
session, ‘Deqi … had to be elicited at all 
points’, and needles were manipulated 
2 to 3 times during the treatment to 
achieve consistent deqi. Independent 
clinical monitors visited the trial centres 
repeatedly to ensure the quality of the 
intervention. The differences between 
the two trials highlights that the effect 
of acupuncture is beyond a simple 
reporting of deqi and the acupuncture 
points selected.
It is not surprising that the recent 
CONSORT statement on trials 
assessing non-pharmacological treatments8 
expanded the ‘Intervention’ section from 
one item in the previous statement9 to 
three items. The recent statement also 
emphasises the inclusion of experienced 
therapists. For instance, trial surgeons 
must be experienced in and comfortable 
with the studied surgical procedure.
WHAT DO I THINK 
ABOUT THE 
RECOMMENDATIONS? 
The authors of the Madsen review should 
have discussed the above-mentioned 
confounding factors before concluding 
that acupuncture has only a small 
analgesic effect that is of little clinical 
relevance. The suggestion of using ‘naïve 
clinicians’ so as to ensure the blinding of 
therapists is not scientifically sound and 
clearly against the CONSORT statement 
as outlined above. Such a suggestion 
will only introduce more variances. 
The suggestion is also unethical, being 
against the International Conference 
on Harmonization Guideline for Good 
Clinical Practice (ICH-GCP) E6 (1996). 
Item 4 states that in order to protect trial 
subjects, the investigators should meet 
‘all the qualifications specified by the 
applicable regulatory requirement(s)’ and 
their qualifications should be up-to-date. 
What would a subject in an acupuncture 
trial think when he or she is told that the 
trial therapist is a ‘naïve’ acupuncturist? 
I think any Human Research Ethics 
Board or Committee that approves such 
practice in acupuncture trials would be 
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deemed to be unethical.
The second recommendation is 
reasonable given the complexity of 
acupuncture. As practitioners, we ought 
to be mindful that the procedure of 
acupuncture enhances its therapeutic 
effect.10 As researchers, we ought to 
find if it is possible to separate the 
physiological and psychological effects 
of acupuncture and how.
CONCLUSION
Overall, the Madsen review provokes 
more questions than it provides answers. 
Future systematic reviews need to take 
the quality of treatment administration 
and adherence to protocol into account. 
These factors of acupuncture treatment 
need to be further studied in relation 
to their impact on the outcomes. In 
addition, before we understand the 
underlying mechanisms of fibromyalgia, 
systematic reviews of pain should not 
confuse wide-spread musculoskeletal 
pain with other types of pain.
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